Browse by author
Lookup NU author(s): Professor Nicola PaveseORCiD, Professor David BrooksORCiD
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
Background: GBA1 is a common genetic risk factor for Parkinson disease which exhibits incomplete penetrance. Objective: To measure microglial activation and dopamine integrity in GBA1 mutation carriers without Parkinson disease, compared to controls. Methods: We performed PET scans on nine GBA1 mutation carriers without Parkinson disease and 29 age matched controls. We measured microglial activation as 11C-(R)-PK11195 binding potentials, and dopamine terminal integrity with 18F-DOPA influx constants.. Results: 11C-(R)-PK11195 binding potentials were increased in the substantia nigra of GBA1 carriers compared to controls (Student’s t test, right t=-3.4 p=0.0022, left t=-4.5, p=0.0001). Statistical Parametric Mapping also localised significantly increased 11C-(R)-PK11195 binding potential in the occipital and temporal lobes, cerebellum, hippocampus, and mesencephalon. Degree of hyposmia correlated with nigral 11C-(R)-PK11195 BPND (Spearman’s rank, right; p=0.031, left; p=0.006). Mean striatal 18F-DOPA uptake was similar to healthy controls. Conclusions: In vivo 11C-(R)-PK11195 PET imaging detects neuroinflammation in brain regions susceptible to Lewy pathology in GBA1 mutation carriers.
Author(s): Mullin S, Stokholm MG, Hughes D, Mehta A, Parbo P, Hinz R, Pavese N, Brooks DJ, Schapira AHV
Publication type: Article
Publication status: Published
Journal: Movement Disorders
Year: 2021
Volume: 36
Issue: 3
Pages: 774-779
Print publication date: 01/03/2021
Online publication date: 05/12/2020
Acceptance date: 19/10/2020
Date deposited: 26/10/2020
ISSN (print): 0885-3185
ISSN (electronic): 1531-8257
Publisher: John Wiley & Sons, Inc.
URL: https://doi.org/10.1002/mds.28375
DOI: 10.1002/mds.28375
Altmetrics provided by Altmetric
